|

PVP-Guided Decongestive Therapy in HF 2

RECRUITINGPhase 4Sponsored by Başakşehir Çam & Sakura City Hospital
Actively Recruiting
PhasePhase 4
SponsorBaşakşehir Çam & Sakura City Hospital
Started2024-07-01
Est. completion2025-07-01
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06495892

Summary

The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion criteria

* Hospitalization for heart failure (de novo or decompensated chronic heart failure) irrespective of left ventricular ejection fraction
* Age 18-99
* Accept to participate

Exclusion criteria

* A prior history of upper extremity venous disease
* Serum creatinine ≥ 3.5 mg/dL
* Severe stenotic valvular disease
* Hypertrophic obstructive cardiomyopathy
* Withdrawal of consent
* Indwelling central venous catheter,
* Implanted left ventricular assist device
* History of heart transplantation
* Clinical diagnosis of cardiogenic shock
* Any right-to-left shunt

Conditions4

CongestionCongestive Heart FailureHeart DiseaseHeart Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.